✦ LIBER ✦

No germline mutations in the histone acetyltransferase geneEP300inBRCA1andBRCA2negative families with breast cancer and gastric, pancreatic, or colorectal cancer

✍ Scribed by Ian G Campbell, David Choong, Georgia Chenevix-Trench

Book ID: 120700410
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 169 KB
Volume: 6
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr803

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Germline mutations of the E-cadherin gen

Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer

✍ Ze Ming Xie; Lai Sheng Li; Claire Laquet; Frédérique Penault-Llorca; Nancy Uhrha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Characteristics of small breast and/or o

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2

✍ Ligtenberg, M J L; Brink, G; Hageman, S; Looij, E Van der; Devilee, P; Wigbout, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

The Relationship Between Psychological D

The Relationship Between Psychological Distress and Personality in Women from Families with Familial Breast/Ovarian or Hereditary Non-polyposis Colorectal Cancer in the Absence of Demonstrated Mutations

✍ Amy Østertun Geirdal; Alv A. Dahl 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 177 KB

Germline mutation and large deletion ana

Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer

✍ Tadeusz Dębniak; Bohdan Górski; Rodney J. Scott; Cezary Cybulski; Krzysztof Mędr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 2 views

## Abstract The __CDKN2A/ARF__ genes have been associated with increased risk of malignant melanoma (MM) in families with multiple members affected by disease and in families characterized by the constellation of breast cancer and MM. The exact contribution of __CDKN2A/ARF__ to disease risk remains

Imatinib mesylate for targeting the plat

Imatinib mesylate for targeting the platelet-derived growth factor β receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer—A dose-escalation Phase I trial

✍ Salah-Eddin Al-Batran; Akin Atmaca; Eberhard Schleyer; Claudia Pauligk; Christia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

## Abstract ## BACKGROUND. In previous experimental models, because of its ability to inhibit the activity of platelet‐derived growth factor β receptor, imatinib decreased the interstitial fluid pressure and improved the delivery and efficacy of anticancer drugs, including fluorouracil. The object

Mutation analysis of the BRCA1 and BRCA2

Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease

✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi